Private Equity Firms Invested $40 Billion in Food Sector
Financial sponsors deployed billions across hundreds of global consumer goods deals through the third quarter of 2026.
Updated on Oct. 7, 2026 in Consumer Goods
Live Poll
Do you trust private equity firms to manage the food and beverage brands you buy?
Private equity firms funneled $40.4 billion into 447 food and beverage deals during the first nine months of 2026. The third quarter alone saw $14.4 billion in activity, with Europe dominating the market by capturing over 70% of the total deal value.
Why it matters
The high volume of transactions reflects a sustained interest from investors in the food and beverage sector, particularly within the health and wellness segments. These capital inflows are reshaping the ownership landscape for global consumer brands as firms look for exits in the coming months.
Investment firms completed 447 transactions totaling $40.4 billion in the first nine months of 2026, including a $1.2 billion buyout of Vitabiotics and a $1 billion growth round for Luckin Coffee. Europe accounted for $8.6 billion of the $14.4 billion in Q3 activity.
The players
Vitabiotics
A British manufacturer of vitamins and minerals that was the subject of a $1.2 billion buyout.
Luckin Coffee
A Chinese coffeehouse chain that secured a $1 billion investment during its recent growth round.
Gong cha Global
An international bubble tea franchise that underwent a $635 million secondary buyout.
Thorne Research
A health and wellness company currently slated for acquisition by a major multinational corporation.
Procter & Gamble
A global consumer goods conglomerate that agreed to purchase a health brand for $3.8 billion.
The details
Activity in the third quarter included 47 European deals and 33 transactions in North America. Major corporate moves include Platinum Equity entering a joint venture involving Nestlé's waters business and L Catterton agreeing to sell Thorne Research to Procter & Gamble for $3.8 billion.
Timeline
2021 served as the baseline year for North American quarterly deal count comparisons.
Q2 2026 saw health and wellness exits account for 21.6% of the total exit value.
Q3 2026 marked the period for the reported $14.4 billion in deal activity.
Q4 2026 is the expected timeframe for the closing of the Thorne Research sale.
Market Landscape
The robust capital deployment mirrors the trajectory set by the 2026 health and wellness exit cycle. This trend highlights a consolidation phase where private equity firms are cycling out of established assets to capture gains in high-growth segments like supplements and hydration.
Consumers may notice shifts in product availability and brand focus as new investors push for growth in the health and wellness segments. These changes often result in updated product lines or pricing adjustments as companies are integrated into larger portfolios.
The takeaway
The sustained interest in the supplement and hydration sectors suggests that sponsors view these categories as essential growth drivers through the end of 2026. Investors should monitor how these large-scale acquisitions impact competitive pricing for consumer health products.
What happens next
The $3.8 billion acquisition of Thorne Research by Procter & Gamble is projected to conclude in the fourth quarter of 2026.
Further reading
For more information on market trends, visit the Consumer Goods section.
Source note: This article includes information reported by Pitchbook.
Live Poll
Do you trust private equity firms to manage the food and beverage brands you buy?
